Dailycsr.com – 29 April 2020 – Alexion continuously attempts push the bar so as to meet patient expectation and coming up with respective solutions. Likewise, the company takes time to comprehend the patient’s emotional and social side besides taking into account their medical condition.
STAR, which means “Solutions To Accelerate Results for patients”, was created in 2019 by Alexion Pharmaceuticals. Through STAR the company has put together a set of method, a framework to hasten solution development across its operations besides integrating “internal and external insights on the patient experience”. STAR aims to gather the “internal and external stakeholders” on a common platform for identifying and solving “urgent patient challenges”. Here are some of the accomplishments achieved through STAR till now, as mentioned by Alexion Pharmaceuticals:
“Creating and implementing the Patient and Stakeholder Value (PSv) model, an enterprise-wide model for deepening our understanding of the patient and stakeholder journeys. “Developing an interactive solution to house patient and stakeholder insights and solutions. “Defining Alexion’s enterprise diagnostic strategy (see Page 42). “Piloting holistic patient and stakeholder experience models for NMOSD, PNH and Wilson disease. As part of these pilots, we created Patient and Stakeholder Experience Factbooks, incorporating patient and caregiver accounts of their experiences, emotions and ethnography insights. “Embedding tangible patient-centric initiatives in the organization and expanding mindsets”. STAR, which means “Solutions To Accelerate Results for patients”, was created in 2019 by Alexion Pharmaceuticals. Through STAR the company has put together a set of method, a framework to hasten solution development across its operations besides integrating “internal and external insights on the patient experience”. STAR aims to gather the “internal and external stakeholders” on a common platform for identifying and solving “urgent patient challenges”. Here are some of the accomplishments achieved through STAR till now, as mentioned by Alexion Pharmaceuticals:
Furthermore, the company’s Head of “International Integration & Transformation”, Asa M. added:
“We are learning the art of what it means to truly listen. It’s a totally different approach where rather than promoting our messages for their response, we humbly listen to continuously understand challenges patients and stakeholders face and the best way we can serve them”.
Take a look at the “2019 Corporate Responsibility Report” of Alexion Pharmaceuticals by clicking on the link given below:
https://csr.alexion.com/
References:
3blmedia.com